Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B To

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3A F Lopez, L B To, Y C Yang, et al.
Cytotherapy|December 9, 2003
Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHDM M Roberts, P Dyson, C Rawling, et al.
Experimental Hematology|June 1, 1990
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral bloodL B To, K M Shepperd, D N Haylock, et al.
Internal Medicine Journal|April 17, 2004
Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approachN Horvath, U Hahn, D Joshua, et al.
Blood|November 1, 1988
Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid seriesA F Lopez, P G Dyson, L B To, et al.
Bone Marrow Transplantation|March 14, 2003
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastimL B To, J Bashford, S Durrant, et al.
Leukemia|May 17, 2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCRC H Hui, K Y Goh, D White, et al.
Leukemia|February 5, 2010
Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitorsD K Hiwase, D L White, J A Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factorR L Basser, L B To, C G Begley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-upR L Basser, L B To, J P Collins, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3A F Lopez, L B To, Y C Yang, et al.
Cytotherapy|December 9, 2003
Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHDM M Roberts, P Dyson, C Rawling, et al.
Experimental Hematology|June 1, 1990
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral bloodL B To, K M Shepperd, D N Haylock, et al.
Internal Medicine Journal|April 17, 2004
Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approachN Horvath, U Hahn, D Joshua, et al.
Blood|November 1, 1988
Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid seriesA F Lopez, P G Dyson, L B To, et al.
Bone Marrow Transplantation|March 14, 2003
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastimL B To, J Bashford, S Durrant, et al.
Leukemia|May 17, 2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCRC H Hui, K Y Goh, D White, et al.
Leukemia|February 5, 2010
Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitorsD K Hiwase, D L White, J A Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factorR L Basser, L B To, C G Begley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-upR L Basser, L B To, J P Collins, et al.
Pageof 12